TON - MARCH 2012 VOL 5, NO 2

TON - MARCH 2012 VOL 5, NO 2 — April 10, 2012

Oophorectomy in younger women leads to decreased bone mineral density (BMD) and a higher prevalence of arthritis, according to a study reported at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium. 

Read More ›

TON - MARCH 2012 VOL 5, NO 2 — April 10, 2012

Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), commonly referred to as non-melanoma skin cancers (NMSCs), are the most common types of cancers in the United States. These 2 cancers account for approximately 2 million cases of skin cancer annually.1 BCC is approximately 4 to 5 times more common than SCC.2 Although rarely metastatic, BCC and SCC can cause substantial local destruction involving extensive areas of soft tissue, cartilage, and bone, as well as disfigurement. Read More ›


TON - MARCH 2012 VOL 5, NO 2 — April 10, 2012

For every nurse there is a patient who you will never forget; the details of that story will not blur over time. In the developing era of personalized medicine, there is that one patient whose story I will not easily forget. It is the story of a 24-year-old male medical student who presented for initial consultation the same week that crizotinib was approved by the FDA for the treatment of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer. 

Read More ›

TON - MARCH 2012 VOL 5, NO 2 — April 10, 2012

Updated results of the phase 3 BOLERO-2 trial demonstrated that adding everolimus to hormonal therapy extends progression-free survival (PFS) in hormone receptor–positive (HR+) metastatic breast cancer that progressed on hormonal therapy with anastrozole or letrozole. The positive outcomes observed in this study suggest that everolimus plus exemestane will be a new option for postmenopausal metastatic HR+ breast cancer.

Read More ›

TON - MARCH 2012 VOL 5, NO 2 — April 10, 2012
Treatment response in patients with acute leukemia is traditionally measured by searching for leukemic cells that persist during chemotherapy. This is done by screening smears of bone marrow aspirates and peripheral blood samples using light microscopy, striving to identify leukemic cells by their morphologic features. Read More ›

TON - MARCH 2012 VOL 5, NO 2 — April 10, 2012

Quinoa, the ancient “grain” of the Andes, cultivated for over 7000 years, has transitioned itself into our present-day kitchens and the title of a modern-day superfood. The Incas believed quinoa to be a sacred food and referred to the “grain” as the “mother seed.” Many years later, this superfood would make its way to the United States, where its popularity continues to grow as its numerous nutritional benefits are spotlighted.

Read More ›

Page 2 of 2


Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: